Cite
He L, Fan Y, Xiao W, et al. Febuxostat attenuates ER stress mediated kidney injury in a rat model of hyperuricemic nephropathy. Oncotarget. 2017;8(67):111295-111308doi: 10.18632/oncotarget.22784.
He, L., Fan, Y., Xiao, W., Chen, T., Wen, J., Dong, Y., Wang, Y., Li, S., Xue, R., Zheng, L., He, J. C., & Wang, N. (2017). Febuxostat attenuates ER stress mediated kidney injury in a rat model of hyperuricemic nephropathy. Oncotarget, 8(67), 111295-111308. https://doi.org/10.18632/oncotarget.22784
He, Li, et al. "Febuxostat attenuates ER stress mediated kidney injury in a rat model of hyperuricemic nephropathy." Oncotarget vol. 8,67 (2017): 111295-111308. doi: https://doi.org/10.18632/oncotarget.22784
He L, Fan Y, Xiao W, Chen T, Wen J, Dong Y, Wang Y, Li S, Xue R, Zheng L, He JC, Wang N. Febuxostat attenuates ER stress mediated kidney injury in a rat model of hyperuricemic nephropathy. Oncotarget. 2017 Nov 30;8(67):111295-111308. doi: 10.18632/oncotarget.22784. eCollection 2017 Dec 19. PMID: 29340054; PMCID: PMC5762322.
Copy
Download .nbib